IC



INVESTOR award winners

In 2016, 28 startup companies were selected to present at the BIOVISION INVESTOR. Recognized based on a set of criteria including youth, performance, ambition and appeal to civil society, these companies illustrate the dynamics of the Life Sciences sector in Europe. The three most promising companies were awarded.



2016 Winners

The most promising and innovative Investor Conference Biotech Startup is



Lemonnier Marc

Antabio SAS

Antabio is a private company, dedicated to the discovery of game-changing treatments of life-threatening and drug-resistant bacterial infections.

Details...
 


The most promising and innovative Investor Conference Medtech Startup is



OSDOIT Anne

SafeHeal

SafeHeal develops a digestive anastomosis protection device, designed to reduce complications & obviate the need for ostomies for colectomy patients.

Details...
 


The Investor Conference Selection committee Special award goes to



SOTTILINI Frederic

CarThera

CarThera improves the prognosis of patients with brain tumours through the development of innovative therapeutic ultrasound-based Medical Devices

Details...
 




2015 Winners

Most promising Biotech company

gensight
Project Holder:
ABRIBAT Thierry

Alizé Pharma

Group of biotech companies specialized in the development of Biopharmaceuticals for Metabolic Diseases and Rare Diseases.

Details...

Most promising Medtech company

cellnovo
Project Holder:
GARRIGUE Stephane

FINEHEART

New type of propulsive synchronized physiologic cardiac pump for NYHE Class III and Class IV heart failure patients

Details...

Special Award

geneuro
Project Holder:
ISABELLE Cuoc

KALLISTEM

Kallistem's objectives are to anticipate and treat male infertility by innovative cell culture production methods.

Details...

2014 Winners

Most promising Biotech company

gensight
Referred by
BIOVISION

GenSight Biologics

GenSight Biologics is an early clinical-stage biopharmaceutical company, pioneering the development of gene therapy-based treatments for retinal degenerative diseases.

Details...

Most promising Medtech company

cellnovo
Referred by
Alexia Perouse

Cellnovo

Cellnovo offers the first patch pump for insulin dependent type 1 diabetes patients built around the benefots of mobile, wireless technology

Details...

Special Award

geneuro
Referred by
Anne-Marie Graffin
Biovision INVESTOR

GeNeuro Innovation SAS

GeNeuro develops biotechnology treatments for disorders associated with endogenous retrovirus expression and presenting high unmet medical needs.

Details...


More About INVESTOR